AAAAAA
Results:
1-14
|
Results: 14
Authors:
LARAQUI CH
BELAMALLEM I
HAROURATE K
LAROUSSI M
BENHAYMOUD N
VERGER C
Citation: Ch. Laraqui et al., SKIN ALLERGIES IN A SHRIMP SHELLING FACTO RY, Revue francaise d'allergologie et d'immunologie clinique, 37(4), 1997, pp. 438-441
Authors:
KAMINSKI M
BOURGINE M
ZINS M
TOURANCHET A
VERGER C
Citation: M. Kaminski et al., RISK-FACTORS FOR RAYNAUDS-PHENOMENON AMONG WORKERS IN POULTRY SLAUGHTERHOUSES AND CANNING FACTORIES, International journal of epidemiology, 26(2), 1997, pp. 371-380
Authors:
TRIMOREAU F
VERGER C
PRALORAN V
DENIZOT Y
Citation: F. Trimoreau et al., NO SEX-RELATED DIFFERENCE IN THE MYELOID ERYTHROID RATIO IN MORPHOLOGICALLY NORMAL BONE-MARROW ASPIRATES/, British Journal of Haematology, 97(3), 1997, pp. 687-687
Authors:
DENIZOT Y
DUPUIS F
TRIMOREAU F
VERGER C
ALLEGRAUD A
PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .4. PLATELET-ACTIVATING-FACTOR INCREASES DNA-SYNTHESIS IN HUMAN BONE-MARROW CELLS, Journal of lipid mediators and cell signalling, 15(1), 1996, pp. 1-4
Authors:
VAS S
VERGER C
OREOPOULOS DG
Citation: S. Vas et al., THE INTERNET AND PERITONEAL-DIALYSIS, Peritoneal dialysis international, 16(2), 1996, pp. 113-113
Authors:
CEBALLOSPICOT I
WITKOSARSAT V
MERADBOUDIA M
NGUYEN AT
THEVENIN M
JAUDON MC
ZINGRAFF J
VERGER C
JUNGERS P
DESCAMPSLATSCHA B
Citation: I. Ceballospicot et al., GLUTATHIONE ANTIOXIDANT SYSTEM AS A MARKER OF OXIDATIVE STRESS IN CHRONIC-RENAL-FAILURE, Free radical biology & medicine, 21(6), 1996, pp. 845-853
Authors:
LARAQUI C
HAROURATE K
BELLAMALLEM I
BENHAYMOUD N
VERGER C
Citation: C. Laraqui et al., THE RESPIRATORY OCCUPATIONAL RISK TO WORK ERS EXPOSED TO ENZYMES IN DETERGENTS, Revue des maladies respiratoires, 13(5), 1996, pp. 485-492
Authors:
DENIZOT Y
ROUGIER F
DUPUIS F
VERGER C
DULERY C
LASKAR M
ALDIGIER JC
PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .8. BIOSYNTHESIS AND METABOLISM OF PAF BY HUMANBONE-MARROW STROMAL CELLS, Experimental hematology, 24(11), 1996, pp. 1327-1332
Authors:
FRIEDLANDER MA
WITKOSARSAT V
NGUYEN AT
WU YC
LABRUNIE M
VERGER C
JUNGERS P
DESCAMPSLATSCHA B
Citation: Ma. Friedlander et al., THE ADVANCED GLYCATION ENDPRODUCT PENTOSIDINE AND MONOCYTE ACTIVATIONIN UREMIA, Clinical nephrology, 45(6), 1996, pp. 379-382
Authors:
DENIZOT Y
TRIMOREAU F
DUPUIS F
VERGER C
PRALORAN V
Citation: Y. Denizot et al., PLATELET-ACTIVATING-FACTOR CONCENTRATIONS IN BONE-MARROW OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES, Leukemia, 9(11), 1995, pp. 1982-1983
Authors:
VERGER C
Citation: C. Verger, HOW TO USE THE PERITONEUM AS A DIALYSIS M EMBRANE MONITORING METHODS,EFFICIENCY CRITERIA, LONGEVITY DETERMINANTS AS DIALYSIS MEMBRANE - IMPLICATIONS FOR PERITONEAL-DIALYSIS TECHNIQUES, Nephrologie, 16(1), 1995, pp. 19-31
PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW
Authors:
DENIZOT Y
TRIMOREAU F
DUPUIS F
VERGER C
PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW, Biochimica et biophysica acta. Molecular cell research, 1265(1), 1995, pp. 55-60
Authors:
DESCAMPSLATSCHA B
HERBELIN A
NGUYEN AT
ROUXLOMBARD P
ZINGRAFF J
MOYNOT A
VERGER C
DAHMANE D
DEGROOTE D
JUNGERS P
DAYER JM
Citation: B. Descampslatscha et al., BALANCE BETWEEN IL-1-BETA, TNF-ALPHA, AND THEIR SPECIFIC INHIBITORS IN CHRONIC-RENAL-FAILURE AND MAINTENANCE DIALYSIS - RELATIONSHIPS WITH ACTIVATION MARKERS OF T-CELLS, B-CELLS, AND MONOCYTES, The Journal of immunology, 154(2), 1995, pp. 882-892
Authors:
LEDESERT B
SAURELCUBIZOLLES MJ
BOURGINE M
KAMINSKI M
TOURANCHET A
VERGER C
Citation: B. Ledesert et al., RISK-FACTORS FOR HIGH BLOOD-PRESSURE AMONG WORKERS IN FRENCH POULTRY SLAUGHTERHOUSES AND CANNERIES, European journal of epidemiology, 10(5), 1994, pp. 609-620
Risultati:
1-14
|